Choose a country ... bioMérieux Argentina bioMérieux Australia bioMérieux Brazil bioMérieux China bioMérieux France bioMérieux Germany bioMérieux Italy bioMérieux Japan bioMérieux Mexico bioMérieux Poland bioMérieux Portugal bioMérieux Russia bioMérieux Spain bioMérieux Switzerland bioMérieux Turkey bioMérieux UK bioMérieux USA Other countries
bioMérieux provides diagnostic solutions (reagents, instruments, software) that determine the source of disease and contamination to improve patient health and ensure consumer safety.
bioMérieux Pandemic Preparedness bioMérieux is contributing its expertise in infectious disease diagnostics to the global effort to address the Influenza A/H1N1 pandemic.
December 1, 2009 bioMérieux’s TEMPO® Gains Approval for Testing E. coli in Food Samples
November 17, 2009 bioMérieux and GSK Sign Theranostics Agreement to Develop Predictive Test for Selecting Breast Cancer Treatment
November 10, 2009 bioMérieux’s VIDAS® System Simplifies the Detection of Salmonella & E. coli O157 Including H7 Strains for the Meat Industry
November 6, 2009 bioMérieux Launches a Molecular Diagnostic MRSA Test on its EasyQ® Automated Platform
June 30, 2009 bioMérieux Launches VIDAS® EBV, a New Test for the Diagnosis of Infectious Mononucleosis
